1226 Federal Register / Vol. 73, No. 4 / Monday, January 7, 2008 / Notices 

Agenda: (1) A report by the Director, 

NICHD; (2) Obstetric and Pediatric 

Pharmacology Branch Presentation; (3) a 

report of the subcommittee on Planning and 

Policy; and other business of the Council. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C-Wing, 

Conference Room 6, Bethesda, MD 20892. 

Closed: 1:30 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C-Wing, 

Conference Room 6, Bethesda, MD 20892. 

Contact Person: Yvonne T. Maddox, PhD, 

Deputy Director, National Institute of Child 

Health and Human Development, NIH, 9000 

Rockville Pike MSC 7510, Building 31, Room 

2A03, Bethesda, MD 20892, (301) 496–1848. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: 

www.nichd.nih.gov/about/nachhd.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program. National 

Institutes of Health, HHS) 

Dated: December 27, 2007. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–6292 Filed 01–04–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Workshops 

Notice is hereby given of a series of 

four scientific workshops organized by 

the Interagency Autism Coordinating 

Committee (IACC). 

The workshops will be closed to the 

public with attendance limited to 

invited participants. The purpose of the 

scientific workshops is to generate 

research priorities that will be used to 

develop the IACC strategic plan for 

Autism Spectrum Disorder (ASD) 

research. The next meeting of the IACC 

when research priorities will be 

discussed is March 14, 2008. 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Type of meeting: Scientific workshops. 

Date: January 15–18, 2008. 

Time: 9 a.m. to 5 p.m. each day. 

Agenda: Review of research 

accomplishments, funding initiatives and 

research resources for ASD by scientists and 

other ASD stakeholders; discussion and 

generation of high priority research areas and 

initiatives for developing the IACC strategic 

plan for ASD research. 

Place: The Westin Arlington Gateway, 801 

North Glebe Road, Arlington, VA 22203, 

703–717–6200. 

Contact Person: Joyce Y. Chung, MD, 

Interagency Autism Coordinating Committee, 

National Institute of Mental Health, NIH, 

6001 Executive Boulevard, NSC, Room 6198, 

Bethesda, MD 20892–9669, 301–443–3621. 

Information about the IACC is available on 

the Web site: http://www.nimh.nih.gov/ 

research-funding/scientific-meetings/ 

recurring-meetings/iacc/index.shtml. 

Dated: December 27, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–6293 Filed 1–4–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse Draft 

Strategic Plan 

AGENCY: National Institute on Drug 

Abuse, NIH, HHS. 

ACTION: Notice. 

SUMMARY: The National Institute on 

Drug Abuse (NIDA) is developing a 

strategic plan for the next 5 years, and 

invites the public to provide comments 

on a draft of this plan. The draft plan 

will be publicly available through the 

NIDA Draft Strategic Plan Web page 

(http://www.drugabuse.gov/ 

StrategicPlan/Index.html) for 30 days 

from the publication of this Notice. The 

public is invited to provide comments 

via the e-mail address or the postal 

address listed on the NIDA Draft 

Strategic Plan Web page. 

Background: NIDA is the lead Federal 

agency for research on drug abuse and 

addiction. For the past three decades, 

NIDA has led the way in supporting 

research to prevent and treat drug abuse 

and addiction and mitigate the impact 

of their consequences—particularly the 

spread of HIV/AIDS and other infectious 

diseases. Given recent revolutionary 

advances in drug abuse research, NIDA 

has recently undergone a strategic 

planning process gathering 

recommendations from the National 

Advisory Council on Drug Abuse and 

from ongoing dialogue with our various 

stakeholder groups to establish 

achievable goals and objectives for the 

future. 

NIDA’s draft Strategic Plan outlines 

four major goal areas—Prevention, 

Treatment, HIV/AIDS, and Cross Cutting 

Priorities—each with Strategic 

Objectives that will guide NIDA’s 

research agenda for the future. The 

public is invited to review this draft 

plan and provide comments. The draft 

plan may be viewed at http:// 

www.drugabuse.gov/StrategicPlan/ 

Index.html, and hard copies are 

available by calling 301–443–1124 or by 

sending a letter requesting a copy (that 

includes your mailing address) to: 

National Institute on Drug Abuse, Attn: 

Draft Strategic Plan, 6001 Executive 

Blvd., Suite 5213, MSC 9561, Bethesda, 

MD 20892–9561. 

Request for Comments: The public is 

invited to provide comments on the 

draft Strategic Plan. Comments may be 

sent to the email address listed on the 

NIDA Strategic Planning Web page at 

http://www.drugabuse.gov/ 

StrategicPlan/Index.html, or to the 

postal address listed above. 

Comments Due Date: Comments 

regarding NIDA’s draft Strategic Plan 

should be submitted via e-mail to 

stratplan@nida.nih.gov no later than 30 

days after the publication of this Notice. 

Comments mailed to the above postal 

address must be postmarked by the 

same date. 

Dated: December 21, 2007. 

Nora D. Volkow, 

Director, National Institute on Drug Abuse, 

National Institutes of Health. 

[FR Doc. E7–25521 Filed 1–4–08; 11:28 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5121–N–35] 

Notice of Proposed Information 

Collection: Comment Request Loan 

Sales Bidder Qualification Statement 

AGENCY: Office of the Assistant 

Secretary for Housing—Federal Housing 

Commissioner, HUD. 

ACTION: Notice. 

SUMMARY: The proposed information 

collection requirement described below 

will be submitted to the Office of 


pwalker on PROD1PC71 with NOTICES